To study the prevalence of GDM and associated outcomes in women visiting GupteHospital and Centre for Research in Reproduction and to evaluate the progression of gestational glucoseintolerance (GGI) during pregnancy
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 20,232
- Locations
- 1
- Primary Endpoint
- Hospital and Centre for Research in Reproduction.
Study Overview
Brief Summary
Gestational diabetes mellitus (GDM) is defined as glucose intolerance during pregnancy. GDM is the most common complication noted due to increased metabolic stress during pregnancy. The prevalence of GDM is increasing globally due to various genetic and lifestyle-related factors. The prevalence of GDM is 10-14.3% in India, which is higher than in western countries.
GDM may leads to an increased risk of fetal and maternal complications. Screening for GDM will help prompt diagnosis and can avoid further complications associated with mother and fetus. It is reported that screening of GDM can be best done during the 24-28 th week of gestation as there is chances of increased insulin resistance during this period.
The Diabetes in Pregnancy Study group India (DIPSI) recommends one-step procedure for diagnosis of GDM.The present study was planned to analyze the prevalence of GDM and associated outcomes in Indian pregnant women.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18.00 Year(s) to 50.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •Pregnant women who had visited Gupte Hospital and Centre for Research in Reproduction and given their consent to use their clinical data for the research purpose.
Exclusion Criteria
- •Any condition that, in the opinion of the investigator, does not justify the patient’s inclusion in the study.
- •Patients not willing to participate in the study.
Outcomes
Primary Outcomes
Hospital and Centre for Research in Reproduction.
Time Frame: Pregnant women who visited hospital during June 2012 to March 2022
Prevalence of Gestation Diabetes Mellitus (GDM) and progression of Impaired Glucose Tolerance (IGT) in patients visiting Gupte
Time Frame: Pregnant women who visited hospital during June 2012 to March 2022
Secondary Outcomes
- Distribution characteristics of GDM patients(Antepartum)
- Pregnancy outcome(Intrapartum)
- Maternal and neonatal outcomes(Postpartum)